Moore Paul Andrew
Officer at ZYME
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 4
- Latest Jan 12, 2026
- Form 144 notices
- 4
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- ZYMEZymeworks Inc.Officer
Sales by reason
Form 4 sales per month, every sale on record.
Timeline
- 1 Form 144 notice ZYMENoticeJan 5, 2024 2024
Filed to sell 9,799 shares ($103k)
Moore Paul Andrew, Officer
No 10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale ZYMEUnusualJan 8, 2024 +3 days
Sold 9,799 shares at $10.79 ($106k)
Moore Paul Andrew, Chief Scientific Officer
No 10b5-1 planSold 57.1% of holdings ($185k position)7,367 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 4 sale ZYMEUnusualJan 6, 2025 +364 days
Sold 21,200 shares at $14.92 ($316k)
Moore Paul Andrew, Chief Scientific Officer
No 10b5-1 planSold 47.6% of holdings ($664k position)23,333 shares leftFollows a Form 144Filing
- 4 Form 144 notice ZYMENoticeJan 6, 2025 same day
Filed to sell 21,200 shares ($307k)
Moore Paul Andrew, Officer
No 10b5-1 planFiling
- 5 Form 4 sale ZYMEUnusualJan 5, 2026 +364 days
Sold 20,110 shares at $25.10 ($505k)
Moore Paul Andrew, Chief Scientific Officer
No 10b5-1 planSold 33.2% of holdings ($1.5M position)40,391 shares leftFollows a Form 144Filing
- 6 Form 144 notice ZYMENoticeJan 5, 2026 same day
Filed to sell 20,110 shares ($535k)
Moore Paul Andrew, Officer
No 10b5-1 planFiling
- 7 Form 4 sale ZYMENo planJan 12, 2026 +7 days
Sold 9,560 shares at $22.67 ($217k)
Moore Paul Andrew, Chief Scientific Officer
No 10b5-1 planSold 16.5% of holdings ($1.3M position)48,497 shares leftFollows a Form 144Filing
- 8 Form 144 notice ZYMENoticeJan 12, 2026 same day
Filed to sell 9,560 shares ($222k)
Moore Paul Andrew, Officer
No 10b5-1 planFiling
Every transaction
Loading transactions…
Sales and notices (8)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2026 | Jan 12, 2026 | ZYME | Officer | Form 144 notice | 9,560 | $222k | Notice | SEC | |
| Jan 12, 2026 | Jan 12, 2026 | ZYME | Chief Scientific Officer | Form 4 sale | 9,560 | $217k | 16.5% | No plan | SEC |
| Jan 5, 2026 | Jan 5, 2026 | ZYME | Officer | Form 144 notice | 20,110 | $535k | Notice | SEC | |
| Jan 5, 2026 | Jan 5, 2026 | ZYME | Chief Scientific Officer | Form 4 sale | 20,110 | $505k | 33.2% | Unusual | SEC |
| Jan 6, 2025 | Jan 6, 2025 | ZYME | Officer | Form 144 notice | 21,200 | $307k | Notice | SEC | |
| Jan 6, 2025 | Jan 6, 2025 | ZYME | Chief Scientific Officer | Form 4 sale | 21,200 | $316k | 47.6% | Unusual | SEC |
| Jan 8, 2024 | Jan 8, 2024 | ZYME | Chief Scientific Officer | Form 4 sale | 9,799 | $106k | 57.1% | Unusual | SEC |
| Jan 5, 2024 | Jan 5, 2024 | ZYME | Officer | Form 144 notice | 9,799 | $103k | Notice | SEC |